No Data
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA (Duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2024 American Society of Hematology Meeting
Secura Bio Appoints Charles R. Romp as Its Chief Executive Officer
Secura/Isaac Group & Consilient Announce Strategic Alliance
Secura: Financial Statements and Related Announcement-Half Yearly Results
Returns On Capital At Secura Group (Catalist:43B) Have Stalled
Sezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura Bio
No Data
No Data
